Lithium and carbamazepine-induced agranulocytosis.
Joffe
R T
RT
Post
R M
RM
D000380:Agranulocytosis / Q000139:chemically induced* / Q000517:prevention & control; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control; D008094:Lithium / Q000627:therapeutic use*; D016651:Lithium Carbonate; D009504:Neutrophils
D016651:Lithium Carbonate; D002220:Carbamazepine; D008094:Lithium